Recent progress using distinct clock mutant animal models crossed with mdx mice, a pre-clinical dystrophin-deficient model for DMD, established the genetic basis for circadian clock interventions to mitigate the disease pathophysiology of muscular dystrophies [55,56]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.